The global Lysosomal Acid Lipase Deficiency Treatment market size is expected to be worth around US$ xx billion by 2030, according to a new report by Vision Research Reports.
The global Lysosomal Acid Lipase Deficiency Treatment market size was valued at US$ 480 million in 2020 and is anticipated to grow at a CAGR of 15.8% during forecast period 2021 to 2030.
Increasing uptake of enzyme replacement therapy, continued use of supportive care therapies, and high unmet needs are some of the key factors driving the market.
Lysosomal acid lipase deficiency (LAL-D) is an autosomal recessive genetic disorder affecting cholesterol metabolism in infants and adults. The disease is caused mainly due to a mutation in the lysosomal acid lipase (LIPA) gene, resulting in the accumulation of either triglyceride and/or cholesteryl esters in different tissues of the body.
The symptoms of LAL deficiency, especially late-onset CESD often overlap with other liver-associated diseases such as nonalcoholic steatohepatitis, viral hepatitis, and autoimmune liver disease, resulting in misdiagnosis by physicians. Approval of first-ever ERT therapy for both WD and CESD has opened up a wave of opportunities for manufacturers to develop tailored therapies for this debilitating disease.
Based on indication, the market has been bifurcated into Wolman disease (WD) and Cholesteryl Ester Storage Disease (CESD). Wolman disease is a more severe form and has an early-onset. It occurs due to the nonexistence of LAL enzyme activity. Infants show no clinical signs at birth, but after a few months suffer from diarrhea, vomiting, jaundice, and develop enlarged livers and spleens. Furthermore, improper absorption of nutrients in the small intestine often results in extreme weight loss in patients.
CESD occurs usually among children and adolescents and has a higher prevalence compared to WD. The diagnosis is poor due to variations in the phenotype of patients and therefore, many cases remain unreported or undiagnosed. The CESD segment is estimated to expand at a higher CAGR during the forecast period, owing to the high disease prevalence and growing uptake of enzyme replacement therapy (ERT).
Current management of LAL deficiency is majorly focused on supportive care and nutritional support. Supportive care for patients includes management of plasma lipid levels, apolipoprotein B production, and high cholesterol and triglycerides through lipid-lowering agents (statins), and a low-fat diet. Furthermore, the progressive nature of the disease often requires patients to undergo a hematopoietic stem cell transplant or liver transplant.
Based on treatment, the global LAL deficiency treatment market is segmented into enzyme replacement therapy, statins, surgery, stem cell transplant, and supportive care. Among these, the ERT segment is anticipated to post the highest CAGR during the forecast period, owing to high efficacy and long-term disease control after treatment. However, major challenges for the LAL-D treatment market remain low awareness and high treatment cost, which limits penetration and creates a financial burden for patients based in underdeveloped and developing markets.
Japan is projected to experience noteworthy growth during the forecast period, due to the approval of Kanuma and improvement in disease diagnosis. The seven major markets together are likely to witness a higher growth rate than the rest of world. There is a critical need for the development of a curative treatment approach that offers improved efficacy and development of new early diagnostic markers to speed up disease diagnosis, worldwide.
Alexion Pharmaceutical Inc., AstraZeneca plc., Merck & Co., Inc., Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.
Wolman Disease (WD)
Cholesteryl Ester Storage Disease (CESD)
Treatment Class Outlook
Enzyme Replacement Therapy
Lipid-Modifying Agents (Statins)
Surgery (Liver Transplant)
Stem Cell Transplantation
The Lysosomal Acid Lipase Deficiency Treatment market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Lysosomal Acid Lipase Deficiency Treatment market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Lysosomal Acid Lipase Deficiency Treatment market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lysosomal Acid Lipase Deficiency Treatment market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Lysosomal Acid Lipase Deficiency Treatment market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Lysosomal Acid Lipase Deficiency Treatment capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Lysosomal Acid Lipase Deficiency Treatment by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Lysosomal Acid Lipase Deficiency Treatment market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Lysosomal Acid Lipase Deficiency Treatment market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Lysosomal Acid Lipase Deficiency Treatment market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Lysosomal Acid Lipase Deficiency Treatment industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Lysosomal Acid Lipase Deficiency Treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Lysosomal Acid Lipase Deficiency Treatment market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Lysosomal Acid Lipase Deficiency Treatment market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Lysosomal Acid Lipase Deficiency Treatment market. These factors have benefited the growth of the global market for Lysosomal Acid Lipase Deficiency Treatment. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Lysosomal Acid Lipase Deficiency Treatment. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Lysosomal Acid Lipase Deficiency Treatment are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Clinical Trial Equipment & Ancillary Solutions Market (By Product: Sourcing, Supply/Logistics, Service, Others; By Phase: Phase I, Phase II, Phase III, Phase IV) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Dental Suction Systems Market (By Product: Wet Suction, Dry Suction; By End-use: Hospitals, Dental Offices) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Dental Caries Detectors Market (By Product: Laser Fluorescent Caries Detector, Fiber Optic Trans-illumination Caries Detector; By End-use: Hospitals, Dental Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Ophthalmic Perimeters Market (By Product: Static, Kinetic, Combination; By End-use: Hospital, Ophthalmic Clinic, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Investigational New Drug CDMO Market (By Product: Small Molecule, Large Molecule; By Service: Contract Development, Contract Manufacturing; By End-use: Pharmaceutical Companies, Biotech Companies, Others (Government, Research Institutes, Academic Institutes, etc.)) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...